封面
市场调查报告书
商品编码
1392034

神经可塑性市场:按产品类型、按应用、按最终用户、按地区

Neuroplasticity Market, By Product Type, By Application (Stroke Rehabilitation, Traumatic Brain Injury Rehabilitation, Neurodegenerative Disorders, Learning and Memory Enhancement, Mental Health Disorders), By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年全球神经可塑性市场规模为65.1亿美元,预计2023年至2030年复合年增长率为27.4%,2030年达到354亿美元。

报告范围 报告详情
基准年 2022年 2023年市场规模 65.1亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 27.40% 2030年市场规模预测 354亿美元
图 1. 2023 年神经可塑性的全球市场占有率(按地区划分)
神经可塑性市场-IMG1

神经可塑性包括各种干预措施,包括神经反馈系统、大脑刺激器、认知训练计划和其他旨在优化大脑功能和促进神经可塑性变化的疗法。

市场动态:

神经系统疾病盛行率的增加和对非侵入性脑刺激技术的需求不断增长是预计在预测期内推动全球神经可塑性市场成长的主要因素。

然而,缺乏认识、有限的研究和开发以及高成本预计将阻碍预测期内神经可塑性市场的成长。

本研究的主要特点

  • 该报告对全球神经可塑性市场进行了详细分析,并提供了以2022年为基准年的预测期(2023-2030)的市场规模和年复合成长率(CAGR%)。
  • 它还阐明了各个细分市场的潜在商机,并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据以下参数(例如公司亮点、产品系列、主要亮点、财务实绩和策略)介绍了全球神经可塑性市场的主要企业。
  • 该报告的见解使行销人员和经营团队负责人就未来的产品发布、类型升级、市场扩张和行销策略做出明智的资讯。
  • 全球神经可塑性市场报告迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球神经可塑性市场的各种策略矩阵,将促进相关人员的决策。

目录

第一章 研究目的与假设

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规及趋势分析

  • 市场动态
    • 神经系统疾病盛行率增加
    • 增加研发活动
    • 技术进步
    • 对非侵入性和个体化治疗的需求不断增长
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章全球神经可塑性市场 -冠状病毒(COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 供需面分析
  • 经济影响

第五章全球神经可塑性市场,依产品类型,2018-2030

  • 基于软体的解决方案
  • 基于硬体的解决方案

第六章 全球神经可塑性市场,依应用分类,2018-2030

  • 中风復健
  • 创伤性脑损伤 (TBI) 康復
  • 神经退化性疾病
  • 增强学习和记忆
  • 心理健康障碍

第七章 全球神经可塑性市场,依最终使用者划分,2018-2030 年

  • 医院和诊所
  • 研究机构和学术中心
  • 製药和生物技术公司
  • 其他的

第八章全球神经可塑性市场,按地区,2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章竞争形势

  • NeuroSky Inc
  • Posit Science Corporation
  • BrainHQ
  • Synaptitude Brain Health
  • Mindmaze SA
  • NeuroVigil Inc.
  • Lumosity
  • Neuronetics, Inc
  • CogniFit
  • SharpBrains
  • Emotiv Inc
  • BrainCo
  • Neuroscape
  • Neuroplast BV
  • Reha Technology AG
  • Virtualware Group
  • Nexeon Medsystems Inc

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6032

The Global Neuroplasticity Market size was valued at US$ 6.51 billion in 2023 and is projected to reach US$ 35.4 billion by 2030, growing at a CAGR of 27.4% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 6.51 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 27.40% 2030 Value Projection: US$ 35.4 Bn
Figure 1. Global Neuroplasticity Market Share (%), By Region, 2023
Neuroplasticity Market - IMG1

Neuroplasticity encompasses various interventions, such as neurofeedback systems, brain stimulation devices, cognitive training programs, and other therapies designed to optimize brain function and promote neuroplastic changes.

Market Dynamics:

The increasing prevalence of neurological disorders and growing demand for non-invasive brain stimulation techniques are major factors expected to drive growth of the global neuroplasticity market during the forecast period.

However, lack of awareness, limited research and development, and high costs are expected to hamper the growth of the neuroplasticity market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global neuroplasticity market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global neuroplasticity market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include NeuroSky Inc., Posit Science Corporation, BrainHQ, Synaptitude Brain Health, Mindmaze SA, NeuroVigil Inc., Lumosity, Neuronetics, Inc., CogniFit, BrainHQ, SharpBrains, Emotiv Inc., BrainCo, Neuroscape, Neuroplast BV, Reha Technology AG, Virtualware Group, Nexeon Medsystems Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global neuroplasticity market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroplasticity market

Neuroplasticity Market Detailed Segmentation:

  • By Product Type:
    • Software-Based Solutions
    • Hardware-Based Solutions
  • By Application:
    • Stroke Rehabilitation
    • Traumatic Brain Injury (TBI) Rehabilitation
    • Neurodegenerative Disorders
    • Learning and Memory Enhancement
    • Mental Health Disorders
  • By End User:
    • Hospitals and Clinics
    • Research Institutes and Academic Centers
    • Pharmaceutical and Biotechnology Companies
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • NeuroSky Inc.
    • Posit Science Corporation
    • BrainHQ
    • Synaptitude Brain Health
    • Mindmaze SA
    • NeuroVigil Inc.
    • Lumosity
    • Neuronetics, Inc.
    • CogniFit
    • BrainHQ
    • SharpBrains
    • Emotiv Inc.
    • BrainCo
    • Neuroscape
    • Neuroplast BV
    • Reha Technology AG
    • Virtualware Group
    • Nexeon Medsystems Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Global Neuroplasticity, By Product Type
    • Market Global Neuroplasticity, By Application
    • Market Global Neuroplasticity, By End User
    • Market Global Neuroplasticity, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of neurological disorders
    • Increasing research and development activities
    • Technological advancements
    • Growing demand for non-invasive and personalized treatments
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Neuroplasticity Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Neuroplasticity Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Software-Based Solutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Hardware-Based Solutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Neuroplasticity Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Stroke Rehabilitation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Traumatic Brain Injury (TBI) Rehabilitation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Neurodegenerative Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Learning and Memory Enhancement
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Mental Health Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Neuroplasticity Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Research Institutes and Academic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Neuroplasticity Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • NeuroSky Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Posit Science Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BrainHQ
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Synaptitude Brain Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mindmaze SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • NeuroVigil Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lumosity
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neuronetics, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CogniFit
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • SharpBrains
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Emotiv Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BrainCo
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neuroscape
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neuroplast BV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Reha Technology AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Virtualware Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nexeon Medsystems Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us